Int J Mol Sci 14:27392752 Powers HJ, Hill MH, Welfare M, Spiers A, Bal W, Russell J et al (2007) Responses of Biomarkers of folate and riboflavin status to folate and riboflavin supplementation in healthy and colorectal polyp patients (The FAB2 Study)
The paradigm for treating people with obesity has often been to recommend lifestyle changes, and then if they develop diabetes or another metabolic condition, to treat them with metformin, insulin, or GLP-1 drugs, says study senior and corresponding author Andrew Stokes, associate professor of global health
Fatima Cody Stanford, MD, MPH, an obesity medicine physician scientist at Massachusetts General Hospital and Harvard Medical School, told Healio that supplements and products such as oatzempic claiming to offer significant weight loss in a short time period often lack rigorous scientific evidence to support their claims, and therefore are not equivalent to medications that are FDA-approved
BenjafieldAVAyasNTEastwoodPRHeinzerRIpMSMMorrellMJet al